Lo Andrew, a director at BridgeBio Pharma ($BBIO), sold common shares on the open market five times in the last year, totaling about $10.2 million. His most recent sale occurred on November 18, 2025. These sales rank 1,103rd among 11,678 individual insiders, above the average sale amount of $8.6 million and close to the average of 6.4 transactions. Lo Andrew made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Director | S | Common Stock | 24007 | $65.23 | 95,665.0000 | 192,708,813 | 20.06% | 0.01% |
| Nov. 18, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Director | S | Common Stock | 30993 | $66.05 | 64,672.0000 | 192,708,813 | 32.40% | 0.02% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Director | S | Common Stock | 36801 | $66.63 | 68,470.0000 | 192,708,813 | 34.96% | 0.02% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Director | S | Common Stock | 3798 | $67.06 | 64,672.0000 | 192,708,813 | 5.55% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Not found | A | Common Stock | 6589 | $0.00 | 160,271.0000 | 190,188,626 | 4.29% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 12, 2025 | AbCellera Biologics Inc. | $ABCL | Lo Andrew | Director | A | Share option (right to buy) | 238864 | $0.00 | 541,354.0000 | 294,327,532 | 78.97% | 0.08% |
| May 2, 2025 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Not found | S | Common Stock | 100000 | $38.50 | 153,682.0000 | 190,188,626 | 39.42% | 0.05% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | AbCellera Biologics Inc. | $ABCL | Lo Andrew | Director | A | Share option (right to buy) | 163934 | $0.00 | 302,490.0000 | 289,166,486 | 118.32% | 0.06% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Lo Andrew | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |